BenirschkeK, DriscollSG. The Pathology of the Human Placenta. Berlin: Springer-Verlag, 1967.
2.
NickelRE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child1988;142:1270–1271.
3.
ClewellWH, ManchesterDK. Recurrent maternal floor infarction: a preventable cause of fetal death. Am J Obstet Gynecol1983;147:346–347.
4.
KatzVL, BowesWAJr., SierkhAE. Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein. Am J Perinatol1987;4:225–228.
5.
AndresRL, KuyperW, ResnikR, PiacquadioKM, BenirschkeK.The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol1990;163:935–938.
6.
MandsagerNT, BendonR, MostelloD, RosennB, MiodovnikM, SiddiqiTA. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol1994;83:750–754.
7.
FukeY, AonoT, ImaiS, SueharaN, FujitaT, NakayamaM.Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Invest1994;38:5–9.
8.
BenirschkeK.Examination of the placenta. Obstet Gynecol1961;61:309–333.
9.
BendonRW, HommelAB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med1996;16:293–297.
VernofKK, BenirschkeK, KephartGM, WasmoenTL, GleichGJ. Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol1992;167:1355–1363.
